ExpressionEdits and Boehringer Ingelheim collaborate to enhance gene therapies
ExpressionEdits in Cambridge has clinched unspecified riches from global pharmaceutical company Boehringer Ingelheim through a collaboration and licensing agreement.
ExpressionEdits in Cambridge has clinched unspecified riches from global pharmaceutical company Boehringer Ingelheim through a collaboration and licensing agreement.